Treatment with the cell-permeable cysteine precursor NAC restored neuronal glutathione levels and prevented neuronal death, supporting the hypothesis that impaired cysteine uptake in EAAT3-depleted neurons underlies the higher susceptibility to oxidative damage after stroke. Here, SLC1A1 is linked to stroke disorder.